ORANGEBURG, N.Y., Oct. 28, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that the Company will release its financial results for the second quarter of fiscal 2014, ended September 30, 2013, after the market closes on Monday, November 11, 2013. Howard Zauberman, Interim Chief Executive Officer, and Keith Darragh, VP, Finance, will host a conference call to discuss the results as follows:
Help employers find you! Check out all the jobs and post your resume.
